Found: 19
Select item for more details and to access through your institution.
Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 820, doi. 10.1002/cpdd.456
- By:
- Publication type:
- Article
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 439, doi. 10.1002/cpdd.364
- By:
- Publication type:
- Article
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.
- Published in:
- Biopharmaceutics & Drug Disposition, 2014, v. 35, n. 7, p. 391, doi. 10.1002/bdd.1909
- By:
- Publication type:
- Article
Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52‐week, open‐label, single‐arm study
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 2, p. 332, doi. 10.1111/jdi.12694
- By:
- Publication type:
- Article
Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 4, p. 443, doi. 10.1111/jdi.12316
- By:
- Publication type:
- Article
Randomized, Controlled, Thorough QT/QTc Study Shows Absence of QT Prolongation with Luseogliflozin in Healthy Japanese Subjects.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139873
- By:
- Publication type:
- Article
Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 3, p. 379, doi. 10.1007/s10157-014-0996-8
- By:
- Publication type:
- Article
Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
- Published in:
- Endocrine Journal, 2015, v. 62, n. 7, p. 593, doi. 10.1507/endocrj.ej15-0097
- By:
- Publication type:
- Article
Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reduction of Excessive Visceral Fat and Safety with 52-Week Administration of Lipase Inhibitor Orlistat in Japanese: Long-Term Clinical Study.
- Published in:
- Advances in Therapy, 2019, v. 36, n. 1, p. 217, doi. 10.1007/s12325-018-0822-x
- By:
- Publication type:
- Article
Reduction of Excessive Visceral Fat and Safety with 52-Week Administration of Lipase Inhibitor Orlistat in Japanese: Long-Term Clinical Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Substantial Effects of Luseogliflozin Revealed by Analyzing Responses to Postprandial Hyperglycemia: Post Hoc Subanalyses of a Randomized Controlled Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of Reduced Renal Function on the Glucose-Lowering Effects of Luseogliflozin, a Selective SGLT2 Inhibitor, Assessed by Continuous Glucose Monitoring in Japanese Patients with Type 2 Diabetes Mellitus.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 5, p. 404, doi. 10.1007/s12325-015-0209-1
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Single-blind, Placebo-controlled Trial.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 4, p. 319, doi. 10.1007/s12325-015-0200-x
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 3, p. 345, doi. 10.1007/s12325-014-0102-3
- By:
- Publication type:
- Article
Favorable therapeutic efficacy of low‐density lipoprotein apheresis for nephrotic syndrome with impaired renal function.
- Published in:
- Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 1, p. 220, doi. 10.1111/1744-9987.13694
- By:
- Publication type:
- Article
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
- Published in:
- Kidney International, 1999, v. 56, p. S227, doi. 10.1046/j.1523-1755.1999.07159.x
- By:
- Publication type:
- Article
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
- Published in:
- Kidney International Supplement, 1999, n. 71, p. S-227
- By:
- Publication type:
- Article